TP53 is not a prognostic marker—clinical consequences of a generally disregarded fact von Braunschmid, Tamara, Kührer, Irene, Mittlböck, Martina, Westerhoff, Maria, Kappel‐Latif, Sonja, Brammen, Lindsay, Krishnadath, Kausilia K., Phillips, Wayne A., Gnant, Michael, Kandioler, Daniela

Volltext

Altered B-Cell Expansion and Maturation in Draining Mesenteric Lymph Nodes of Inflamed Gut in Crohn’s Disease von Kappel-Latif, Sonja, Kotagiri, Prasanti, Schlager, Lukas, Schuld, Gabor, Walterskirchen, Natalie, Schimek, Vanessa, Sewell, Gavin, Binder, Carina, Jobst, Johanna, Murthy, Supriya, Messner, Barbara, Dabsch, Stefanie, Kaser, Arthur, Lyons, Paul A., Bergmann, Michael, Stift, Anton, Oehler, Rudolf, Unger, Lukas W.

Volltext

Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected von Kappel-Latif, Sonja, Zacherl, Johannes, Hejna, Michael, Westerhoff, Maria, Tamandl, Dietmar, Ba-Ssalamah, Ahmed, Mittlböck, Martina, Wolf, Brigitte, Wrba, Friedrich, Kührer, Irene, Pluschnig, Ursula, Schoppmann, Sebastian F., Függer, Reinhold, Zwrtek, Ronald, Glaser, Karl, Karner, Josef, Längle, Friedrich, Wenzl, Etienne, Roka, Rudolf, Öfner, Dietmar, Tschmelitsch, Jörg, Hold, Michael, Keil, Felix, Gnant, Michael, Kandioler, Daniela

Volltext